Madrigal Pharmaceuticals, Inc. (FRA:YDO1)

Madrigal Pharmaceuticals Revenue

Madrigal Pharmaceuticals had revenue of $287.27M USD in the quarter ending September 30, 2025, with 362.03% growth. This brings the company's revenue in the last twelve months to $740.64M, up 864.21% year-over-year. In the year 2024, Madrigal Pharmaceuticals had annual revenue of $180.13M.

• Revenue (ttm): $740.64M
• Revenue Growth: +864.21%
• P/S Ratio: 14.82
• Revenue / Employee: $1.40M
• Employees: 528
• Market Cap: 9.35B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	180.13M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	147.00K	-7.44M	-98.06%
Dec 31, 2011	7.58M	-7.22M	-48.77%
Dec 31, 2010	14.80M	-129.44M	-89.74%
Dec 31, 2009	144.25M	141.63M	5,416.06%
Dec 31, 2008	2.62M	-	-
Dec 31, 2007	-	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	-	-	-